In this study, we have utilized a well-maintained, retrospectively collected dataset of sequential breast cancer patients to explore the clinicopathological characteristics and outcomes of patients with ER-/PgR+ breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.